» Articles » PMID: 12227130

Glucocorticoid Withdrawal Schemes in Chronic Medical Disorders. A Systematic Review

Overview
Publisher Elsevier
Specialty Endocrinology
Date 2002 Sep 14
PMID 12227130
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

This systematic review highlights the uncertainty about the safety and efficacy of glucocorticoid withdrawal in many chronic diseases, elucidating the need for further research in this area. The problem of glucocorticoid withdrawal seems to be good example for wide variation in physicians' approaches to weaning patients off glucocorticoids. This practice variation appears justified, given the well known extraordinary array of individual reactions to systemic glucocorticoid therapy [44], the obligation to individualize treatment, and scientific uncertainty. Moreover, only sparse information concerning health-related quality of life, well-being and symptoms, and socioeconomic sequelae after glucocorticoid withdrawal is available from published randomized trials. In conclusion, clinicians and patients need many more--and in a number of conditions, initial--high quality studies to assess the safety and efficacy of systemic glucocorticoid withdrawal schedules in chronic diseases.

Citing Articles

High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor associated hypophysitis (CORTICI): an open, randomised controlled trial.

Theiler-Schwetz V, Trummer C, Schmitt L, Terbuch A, Obermayer-Pietsch B, Richtig E Ann Med. 2025; 57(1):2453829.

PMID: 39862267 PMC: 11770865. DOI: 10.1080/07853890.2025.2453829.


The Glucocorticoid Taper: A Primer for the Clinicians.

Priya G, Laway B, Ayyagari M, Gupta M, Bhat G, Dutta D Indian J Endocrinol Metab. 2024; 28(4):350-362.

PMID: 39371659 PMC: 11451960. DOI: 10.4103/ijem.ijem_410_23.


European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency.

Beuschlein F, Else T, Bancos I, Hahner S, Hamidi O, van Hulsteijn L J Clin Endocrinol Metab. 2024; 109(7):1657-1683.

PMID: 38724043 PMC: 11180513. DOI: 10.1210/clinem/dgae250.


Glucocorticoid-Induced Osteoporosis (GIOP).

Jha S Indian J Orthop. 2023; 57(Suppl 1):181-191.

PMID: 38107807 PMC: 10721764. DOI: 10.1007/s43465-023-01037-8.


Long-Term Usage of Oral Glucocorticoids Leading to Adrenal Insufficiency: A Comprehensive Review of the Literature.

Monge Chacon A, Wang C, Waqar D, Syeda S, Kumar R, Meghana D Cureus. 2023; 15(5):e38948.

PMID: 37309331 PMC: 10257969. DOI: 10.7759/cureus.38948.